Bristol-Myers Squibb

Yahoo Finance • yesterday

Is Bristol-Myers Squibb (BMY) One of the Best Healthcare Stocks to Buy According to Billionaires?

We recently published a list of 10 Best Healthcare Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other best healthcare stocks to invest... Full story

Yahoo Finance • 2 days ago

Beat the S&P 500 With This Cash-Gushing Dividend Stock

Investors seeking relief from stock market volatility should take a closer look at Bristol Myers Squibb(NYSE: BMY). At the time of writing, shares of the healthcare giant have climbed 4% year to date -- a notable outlier amid the broader s... Full story

Yahoo Finance • 4 days ago

Jim Cramer on Bristol-Myers Squibb. Co (NYSE:BMY): They Should Have Known Better

We recently published a list of Jim Cramer Discusses These 11 Stocks & Reveals Why Tech Stocks Are Down. In this article, we are going to take a look at where Bristol-Myers Squibb. Co (NYSE:BMY) stands against other stocks that Jim Cramer... Full story

Yahoo Finance • 5 days ago

50-Year-Old Early Retiree Making $175,000 in Dividends Shares Portfolio - 'Now I Spend on Travel, Cars and Doing What I Want'

Dividend investing is back on investors' radar after taking a backseat during the AI-led bull run. With tariff uncertainties and fading momentum in AI stocks, investors are looking for stable dividend-paying companies to navigate the curre... Full story

Yahoo Finance • 6 days ago

Positive phase III data gives Merck potential boost for blockbuster Keytruda in injection form

Merck (MRK) released phase III data for an injection form of its blockbuster cancer treatment drug Keytruda and announced the FDA is reviewing the application for approval. The data showed that when given to patients with a type of lung c... Full story

Yahoo Finance • 7 days ago

Global Radiotherapy Market Expected to Reach $9.62 Billion By 2030 Realizing Growth Due to Technological Advancements

PALM BEACH, Fla., March 27, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Industry experts see the global radiotherapy market continuing to grow in the years to come. A recent report from MarketsAndMarkets said that the globa... Full story

Yahoo Finance • 7 days ago

3 Deeply Discounted Dividend Stocks to Buy Today

Want to buy a good dividend stock and secure a great price in the process? I have a list of three stocks that can help you diversify your portfolio, allow you to earn above-average dividends, and score some potential bargains in the proces... Full story

Yahoo Finance • 9 days ago

Is Bristol-Myers Squibb (BMY) The Best Healthcare Dividend Stock to Invest in?

We recently published a list of 13 Best Healthcare Dividend Stocks to Invest in. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other best healthcare dividend stocks to invest i... Full story

Yahoo Finance • 19 days ago

Why Bristol-Myers Squibb Company (BMY) Went Down On Thursday?

We recently published a list of Friday’s 10 Worst Performing Stocks. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other Friday’s worst performing stocks. Wall Street’s main i... Full story

Yahoo Finance • 26 days ago

Jim Cramer Highlights ‘Multi-Billionaire Dollar’ Catalyst for Bristol-Myers Squibb Company (BMY)

We recently published a list of Jim Cramer’s Latest Portfolio: Top 10 Stocks to Watch. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other top stocks to watch from Jim Cramer’s... Full story

Yahoo Finance • 29 days ago

Bristol-Myers Squibb (NYSE:BMY) Declares US$0.62 Dividend On Common Stock And US$0.50 On Preferred Stock

Bristol-Myers Squibb recently declared a quarterly dividend of $0.62 per share on its common stock, reinforcing its ongoing strategy to return value to shareholders. This announcement correlates with the company’s 3% price increase last we... Full story

Yahoo Finance • 30 days ago

Bristol-Myers Squibb Company (BMY): Among the Best S&P 500 Dividend Stocks to Buy Now

We recently compiled a list of the 15 Best S&P 500 Dividend Stocks to Buy Now.In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against the other stocks. Stock market investors have enjoy... Full story

Yahoo Finance • 30 days ago

Bristol Myers Squibb Announces Dividend

PRINCETON, N.J., March 03, 2025--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has declared a quarterly dividend of sixty-two cents ($0.62) per share on the $0.10 par value common stock of th... Full story

Yahoo Finance • last month

Why Bristol-Myers Squibb Co (BMY) Went Up On Monday?

We recently published a list of 10 Stocks Grow Firmer Despite Mixed Market Sentiment. In this article, we are going to take a look at where Bristol-Myers Squibb Co (NYSE:BMY) stands against other stocks that grow firmer despite mixed marke... Full story

Yahoo Finance • last month

U.S. Food and Drug Administration Accepts Bristol Myers Squibb’s Supplemental Biologics License Application for Opdivo® Plus Yervoy® for Patients with Unresectable or Metastatic Microsatellite Instability-High or Mismatch Repair Deficient...

Application based on analyses from the Phase 3 CheckMate -8HW clinical trial, in which Opdivo plus Yervoy demonstrated superior progression-free survival compared to Opdivo monotherapy and investigator’s choice of chemotherapy The U.S. Fo... Full story

Yahoo Finance • last month

Why Is Cancer-Focused Exelixis Stock Trading Higher On Friday?

Why Is Cancer-Focused Exelixis Stock Trading Higher On Friday? On Friday, Exelixis, Inc. (NASDAQ:EXEL) authorized repurchasing up to an additional $500 million of the company’s common stock before December 31, 2025. Exelixis plans to com... Full story

Yahoo Finance • last month

Bristol Myers Cancer Drug Opdivo In Combination With Chemo Shows Improved Overall Survival In Certain Patients With Lung Cancer

On Wednesday, Bristol Myers Squibb & Co (NYSE:BMY) announced the final analysis of overall survival (OS) from the Phase 3 CheckMate -816 study, which evaluated Opdivo (nivolumab) in combination with platinum-doublet chemotherapy as a neoad... Full story

Yahoo Finance • 2 months ago

Mark Hillman Exits Simon Property Group Inc, Impacting Portfolio by -3.28%

Insightful Moves in Hillman Capital's Fourth Quarter 2024 13F Filing Mark Hillman (Trades, Portfolio) recently submitted the 13F filing for the fourth quarter of 2024, providing insights into his investment moves during this period. Mark... Full story

Yahoo Finance • 2 months ago

Canadian Pacific Kansas City Ltd Dominates Sarah Ketterer's Q4 2024 Portfolio

Insightful Moves by a Renowned Value Investor Sarah Ketterer (Trades, Portfolio) recently submitted the 13F filing for the fourth quarter of 2024, providing insights into her investment moves during this period. Sarah Ketterer (Trades, Po... Full story

Yahoo Finance • 2 months ago

68-Year-Old Earning $4,300/Month in Dividends Shares His Top 7 Stock Picks — 'Dividends Have Been Consistent, Stable'

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. U.S. markets were seeing volatility as technology earnings began to worry investors due to soft forecasts and mounting AI-related expense... Full story